Delivery Order SPE2DB20D2104-SPE2DB26FMAEY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $1,514.37. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, utilizes firm fixed pricing under a non-set-aside, competitively awarded delivery order. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $2,551.48. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Brilinta 90 mg tablets (60-count) valued at $2,535.30, with an ultimate completion date of September 26, 2025. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order for pharmaceutical supply. The contract was fulfilled by AmerisourceBergen's Corporate Office division, with performance taking place at the company's headquarters in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,340.98 to AmerisourceBergen Drug Corp for the supply of Brilinta 60 mg tablets (60-count units) with a completion date of September 23, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,893.27 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (100 unit dose packages) on September 15, 2025, with completion targeted for September 16, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through the federal procurement process. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,926.42 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (quantity 60s) on August 26, 2025, with completion scheduled for August 27, 2025. This firm fixed price delivery order represents a non-set-aside award executed through open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the federal government's pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,451.98 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count units) under a firm fixed price contract. The award was made on August 4, 2025, with an ultimate completion date of August 5, 2025, and represents a non-competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) under a firm fixed-price contract valued at $3,329.04. This non-set-aside delivery order represents the continuation of pharmaceutical supply services to support federal medical procurement needs, with an ultimate completion date of September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,248.39 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of August 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Brilinta 90 mg tablets (60-count units) at a ceiling value of $4,019.96. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's broader pharmaceutical supply contract vehicle. The order is scheduled for completion by August 28, 2025, with the place of performance at AmerisourceBergen's corporate office...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMAEYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,941.37 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count packages). This competitively awarded, firm fixed-price delivery order was issued on October 16, 2025, with an ultimate completion date of October 17, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and represents a child contract under the company's larger pharmaceutical supply agreement with the federal government. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling the company to supply a comprehensive range of medications, vaccines, and medical supplies to support military healthcare programs and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The current award demonstrates the company's continued role as a critical pharmaceutical distributor within the federal medical supply chain, fulfilling routine medication procurement needs for defense and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 10/16/25 |